Radiopharm Theranostics Limited American Depositary Shares (RADX)

• Market cap: $31.4M
• 1 day: 3.32%
• 5 days: -3.58%
• 1 month: -13.68%
• 3 months: -8.80%
• 6 months: -77.14%
• Year to date: -12.93%
• 1 year: -77.14%
• 5 years: -77.14%
• 10 years: -77.14%
• Sector: Healthcare
• Industry: Biotechnology

About: Radiopharm Theranostics Ltd is an Australian based clinical-stage radiotherapeutics company which is targeting cancer. The company has a pipeline of around four licensed platform technologies, with diagnostic and therapeutic applications in both pre-clinical and clinical stages of development. The company is engaged in research, development and commercialization of health technologies.

Fund manager confidence

Based on 2024 Q4 regulatory disclosures by fund managers ($100M+ AUM)

0.02% more ownership

Funds ownership: 0% [Q3] → 0.02% (+0.02%) [Q4]

Research analyst outlook

2 Wall Street Analysts provided 1 year price targets over the past 3 months

• Low target: $12 197% upside
• Avg. target: $13.50 234% upside
• High target: $15 271% upside

2 analyst ratings

• positive: 2 100%
• neutral: 0 0%
• negative: 0 0%

Maxim Group Michael Okunewitch 13% 1-year accuracy 1 / 8 met price target	197% upside $12	Buy Initiated	1 May 2025
B. Riley Securities Yuan Zhi 38% 1-year accuracy 3 / 8 met price target	271% upside $15	Buy Initiated	12 Mar 2025